Antidigoxin antiserum prevents endogenous digitalis-like compound-mediated reperfusion injury via modulating sodium pump isoform gene expression

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 1, 2010, Pages 38-44

  Wang, He Gui ^a,b   Chu, Yue Feng ^a   Zou, Jian Gang ^b   Ke, Yong Sheng ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Antidigoxin antiserum; Endogenous digitalis like compound; Myocardial ischemia reperfusion injury; Na+ K+ ATPase; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTISERUM; DIGITALIS; DIGOXIN ANTIBODY; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION SIZE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARDENOLIDES; DIGOXIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNE SERA; ISOENZYMES; MALE; MYOCARDIAL REPERFUSION INJURY; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 76149139770     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-107     Document Type: Article

References (28)

1. Bagrov, A.Y., and Shapiro, J.I. 2008. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat. Clin. Pract. Nephrol. 4(7): 378-392. doi:10.1038/ncpnepho848. PMID:18542120.
2. Bagrov, A.Y., Fedorova, O.V., Roukoyatkina, N.I., and Zhabko, E.P. 1993. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats. Cardiovasc. Res. 27(6): 1045-1050. doi:10.1093/cvr/27.6.1045. PMID:8221762.
3. Bagrov, A.Y., Kuznetsova, E.A., and Fedorova, O.V. 1994. Endogenous digoxin-like factor in acute myocardial infarction. J. Intern. Med. 235(1): 63-67. doi:10.1111/j.1365-2796.1994.tb01033.x. PMID:8283162.
4. Bhuiyan, M.S., and Fukunaga, K. 2007. Inhibition of HtrA2/Omi ameliorates heart dysfunction foil following ischemia/reperfusion injury in rat heart in vivo. Eur. J. Pharmacol. 557(2-3): 168-177. doi:10.1016/j.ejphar.2006.10. 067. PMID:17182030.
5. Blanco, G., and Mercer, R.W. 1998. lsozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275(5 Pt 2): F633-F650. PMID:9815123.
6. Elmoselhi, A.B., Lukas, A., Ostadal, P., and Dhalla, N.S. 2003. Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts. Am. J. Physiol. Heart Circ. Physiol. 285(3): H1055-H1063. PMID:12763751.
7. Guo, X., Wang, J., Elimban, V., and Dhalla, N.S. 2008. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction. Can. J. Physiol. Pharmacol. 86(4): 139-147. doi:10.1139/Y08-006. PMID:18418421.
8. Harada, K., Komuro, I., Hayashi, D., Sugaya, T., Murakami, K., and Yazaki, Y. 1998. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation. 97(4): 315-317. PMID:9468203.
9. Harada, K., Lin, H., Endo, Y., Fujishiro, N., Sakamoto, Y., and Inoue, M. 2006. Subunit composition and role of Na-+-,K+-ATPases in ventricular myocytes. J. Physiol. Sci. 56(1): 113-121. doi:10.2170/physiolsci .RP001905. PMID:16779919.
10. Hayashi, T., Ijiri, Y., Toko, H., Shimomura, H., Okabe, M., Terasaki, F., et al. 2000. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Eur. Heart J. 21(4): 296-305. doi:10.1053/euhj.1999.1744. PMID:10653677.
11. Hiekey, A.R., Wenger, T.L., Carpenter, V.P., Tilson, H.H., Hlatky, M.A., Furberg, C.D., et al. 1991. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J. Am. Coll. Cardiol. 17(3): 590-598. PMID: 1993775.
12. Imahashi, K., Nishimura, T., Yoshioka, J., and Kusuoka, H. 2001. Role of intracellular Na(+) kinetics in preconditioned rat heart. Circ. Res. 88(11): 1176-1182. doi:10.1161/hh1101.092139. PMID:11397784.
13. Kaide, J., Ura, N., Torii, T., Nakagawa, M., Takada, T., and Shimamoto, K. 1999. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats. Am. J. Hypertens. 12(6): 611-619. doi:10.1016/S0895- 706h(99)00029-1. PMID:10371371.
14. Kato, K., Lukas, A., Chapman, D.C., and Dhalla, N.S. 2000. Changes in the expression of cardiac Na+-K+ ATPase subunits in the UM-X7.1 cardiomyopathic hamster. Life Sci. 67(10): 1175-1183. doi:10.1016/S0024-3205(00)00709-8. PMID:10954051.
15. Ke, Y.S. 2001. Endoxin:a major factor regulating cardiovascular system. Acta Pharmacol. Sin. 22(3): 201-209. PMID:11742565.
16. Ke, Y.S., Liu, Z.F., Wang, D.G., and Wang, H.G. 2004a. Effects of antidigoxin antiserum on endoxin levels, apoptosis and the expression of Bax and Bcl-2 protein in ischaemia-reperfusion myocardium. Clin. Exp. Pharmacol. Physiol. 31(10): 691-695. doi:10.1111/j.1440-1681.2004.04070.x. PMID:15554909.
17. Ke, Y.S., Wang, H.G., Wang, D.G., and Zhang, G.B. 2004b. Endoxin-mediated myocardial ischemia reperfusion injury in rats in vitro. Can. J. Physiol. Pharmacol. 82(6): 402-408. doi:10.1139/y04-041. PMID:15381964.
18. Ostadal, P., Elmoselhi, A.B., Zdobnicka, I., Lukas, A., Chapman, D., and Dhalla, N.S. 2003. Ischemia-reperfusion alters gene expression of Na+-K+ ATPase isoforms in rat heart. Biochem. Biophys. Res. Commun. 306(2): 457-462. doi:10.1016/S0006-291X(03)00986-0. PMID:12804585.
19. Ota, S., Nishikawa, H., Takeuchi, M., Nakajima, K., Nakamura, T., Okamoto, S., et al. 2006. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revasculanization Trial (SMART). Circ. J. 70(9): 1099-1104. doi:10.1253/circj.70.1099. PMID:16936418.
20. Pasdois, P., Quinlan, C.L., Rissa, A., Tariosse, L., Vinassa, B., Costa, A.D., et al. 2007. Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS. Am. J. Physiol. Heart Circ. Physiol. 292(3): 111470-111478. doi:10.1152/ajpheart.00877. 2006. PMID:17098831.
21. Pierre, S.V., Yang, C., Yuan, Z., Seminerio, J., Mouas, C., Garlid, K.D., et al. 2007. Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts. Cardiovasc. Res. 73(3): 488-496. doi:10.1016/j.cardiores.2006. 11.003. PMID:17157283.
22. Piper, H.M., Meuter, K., and Schäfer, C. 2003. Cellular mechanisms of ischemia-reperfusion injury. Ann. Thorac. Surg. 75(2): S644-S648. doi:10.1016/S0003-4975(02)04686-6. PMID:12607706.
23. Pullen, M.A., Brooks, D.P., and Edwards, R.M. 2004. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids. J. Pharmacol. Exp. Ther. 310(1): 319-325. doi:10.1124/jpet.104.065250. PMID: 14982968.
24. Schoner, W., and Scheiner-Bobis, G. 2007. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 293(2): C509-C536. doi:10.1152/ajpcell.00098.2007. PMID:17494630.
25. Shandelya, S.M., Kuppusamy, P., Weisfeldt, M.L., and Zweier, J.L. 1993. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation. 87(2): 536-546. PMID:8381059.
26. Wang, Q.D., Pernow, J., Sjöquist, P.O., and Rydén. L. 2002. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc. Res. 55(1): 25-37. doi:10.1016/S0008-6363(02)00261-4. PMID:12062706.
27. Yellon, D.M., and Hausenloy, D.J. 2007. Myocardial reperfusion injury. N. Engl. J. Med. 357(11): 1121-1135. doi:10.1056/NEJMra071667. PMID:17855673.
28. Zweier, J.L., and Talukder, M.A. 2006. The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 70(2): 181-190. doi:10.1016/j.cardiores.2006.02.025. PMID:16580655.